Терминологические и классификационные аспекты Бетестовской системыклассифицирования цитологических заключений щитовидной железы

Статья посвящена возможностям применения Бетестовской системы интерпретации результатов тонкоигольной аспирационной биопсии (ТАБ). Представлены современные данные об основных отличиях, а также преимуществах новой классификации. Применение Бетестовской системы классифицирования приводит к повышению чувствительности и специфичности ТАБ

щитовидная железа, ТАБ, цитологическое заключение

1. Abele J.S., Levine R.A. Diagnostic criteria and risk-adapted approach to indeterminate thyroid cytodiagnosis. Cancer Cytopathol. 2010; 118: 415–422. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocrinol. Pract. 2006; 12: 63–103.

2. Baloch Z.W., Livolsi V.A., Asa S.L. et al. Diagnostic terminology and morphological criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute thyroid fine- needle aspiration state of the science conference. Diagn. Cytopathol. 2008; 36: 425–433.

3. Caraci P., Aversa S., Mussa A. et al. Role of fineneedle aspiration biopsy and frozen-section evaluation in the surgical management of thyroid nodules. Br. J. Surg. 2002; 89: 797–701.

4. Cibas E.S., Alexander E.K., Benson C.B. et al. Indications for Thyroid FNA and Pre-FNA Requirements: A Synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn. Cytopathol. 2008; 36: 390–399.

5. Cibas E.S., Ali S.Z. The Bethesda System for Reporting Thyroid Cytopathology. Am. J. Clin. Pathol. 2009; 132: 658–665.

6. Cooper D.S., Doherty G.M., Haugen B.R. et al. Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. The American Thyroid Association Guidelines Taskforce. Thyroid. 2006; 16: 1–33.

7. Duek S.D., Goldenberg D., Linn S. et al. The role of fineneedle aspiration and intraoperative frozen section in the surgical management of solitary thyroid nodules. Surg. Today. 2002; 32: 857–861.

8. Jo V.Y., Van der Laan P.A., Marqusee E., Krane J.F. Repeatedly Nondiagnostic Thyroid Fine-Needle Aspirations Do Not Modify Malignancy Risk. Acta Cytol. 2011; 55: 539–543.

9. Koen T.M., Mody D.R., Scheiber-Pacht M. et al. Limiting the use of atypical/inconclusive as a category in nongynecologic cytology specimens. Arch. Pathol. Lab. Med. 2010; 134: 1016–1019.

10. Luu M.H., Fischer A.H., Stockl T.J. et al. Atypical Follicular Cells with Equivocal Features of Papillary Thyroid Carcinoma Is Not a Low-Risk Cytologic Diagnosis. Acta Cytol. 2011; 55: 526–530.

11. Marchevsky A.M., Walts A.E., Bose S. et al. Evidence-based evaluation of the risks of malignancy predicted by thyroid fine-needle aspiration biopsies. Diagn. Cytopathol. 2010; 38: 252–259.

12. Nayar R., Ivanovic M. The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer Cytopathol. 2009; 117: 195–202.

13. NCI Thyroid Fine Needle Aspiration State of Science Conference. Diagn. Cytopathol. 2008; 6: 388–448.

14. Ohori N.P., Schoedel K.E. Variability in the Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Diagnosis in the Bethesda System for Reporting Thyroid Cytopathology: Sources and Recommendations. Acta Cytol. 2011; 55: 492–498.

15. Olson M.T., Clark D.P., Erozan Y.S., Ali S.Z. Spectrum of Risk of Malignancy in Subcategories of ‘Atypia of Undetermined Significance’. Acta Cytol. 2011; 5: 518–525. Pu R.T., Yang J., Wasserman P.G. et al. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Diagn. Cytopathol. 2006; 34: 330–334.

16. Renshaw A.A. Should ‘atypical follicular cells’ in thyroid fine-needle aspirates be subclassified? Cancer Cytopathol. 2010; 118: 186–189.

17. Sebo T.J. What are the keys to successful thyroid FNA interpretation? Clin. Endocrinol. 2012; 77: 13–17.

18. Somma J., Schlecht N.F., Fink D. et al. Thyroid fine needle aspiration cytology: follicular lesions and the gray zone. Acta Cytol. 2010; 54: 123–131.

19. Theoharis C.G.A., Schofield K.M., Hammers L. et al. The Bethesda Thyroid Fine-Needle Aspiration Classification System: Year 1 at an Academic Institution. Thyroid. 2009; 19: 1215–1226.

20. Van der Laan P.A., Marqusee E., Krane J.F. Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated FNA be the preferred initial approach? Am. J. Clin. Pathol. 2011; 135: 770–775.

21. Van der Laan P.A., Renshaw A.A., Krane J.F. Atypia of undeter- mined significance and nondiagnostic rates in the Bethesda system for reporting thyroid cytopathology are inversely related. Am. J. Clin. Pathol. 2012; 137: 462–465.

22. Wang C.C., Friedman L., Kennedy G.C. et al. A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid. 2011; 21: 243–251.

23. Yang J., Schnadig V., Logrono R., Wasserman P.G. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer. 2007; 111: 306–315.

24. Yassa L., Cibas E.S., Benson C.B. et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer. 2007; 111: 508–516.

25. Gia-Khanh N., Lee M.W., Ginsberg J., Wragg T. Darcy Bilodeau Fine-needle aspiration of the thyroid: an overview. CytoJournal. 2005; 2: 12.

26. Ali S.Z., Cibas E.S., eds. Atlas "The Bethesda System for Reporting Thyroid Cytopathology". New York: Springer, 2010.